Back to Search
Start Over
Lorlatinib Salvages CNS Relapse in an ALK-Positive Non–Small-Cell Lung Cancer Patient Previously Treated With Crizotinib and High-Dose Brigatinib
- Source :
- Clinical Lung Cancer. 20:e133-e136
- Publication Year :
- 2019
- Publisher :
- Elsevier BV, 2019.
- Subjects :
- Adult
Central Nervous System
Male
Pulmonary and Respiratory Medicine
Oncology
Cancer Research
medicine.medical_specialty
Lung Neoplasms
Lactams
Brigatinib
Lactams, Macrocyclic
Aminopyridines
Antineoplastic Agents
Article
Organophosphorus Compounds
Crizotinib
Recurrence
Carcinoma, Non-Small-Cell Lung
Internal medicine
Carcinoma
medicine
Humans
Anaplastic Lymphoma Kinase
Neoplasm Metastasis
Lung cancer
Drug Approval
business.industry
ALK-Positive
medicine.disease
Lorlatinib
Pyrimidines
Treatment Outcome
Pyrazoles
Non small cell
Previously treated
business
medicine.drug
Subjects
Details
- ISSN :
- 15257304
- Volume :
- 20
- Database :
- OpenAIRE
- Journal :
- Clinical Lung Cancer
- Accession number :
- edsair.doi.dedup.....83289f48e00b0e777f4751369210f14b